RADNOR, PA — Altasciences and Certara (Nasdaq: CERT) formed a strategic partnership aimed at integrating modeling and simulation technologies into early-stage drug development programs as pharmaceutical companies seek to reduce failure rates before human trials. The companies said the collaboration will combine Altasciences’ drug development platform with Certara’s model-informed drug development software and strategic consulting services. The p…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.